AAAAAA

   
Results: 1-25 | 26-41
Results: 1-25/41
SOLUBLE P-SELECTIN GLYCOPROTEIN LIGAND-1 (SPSGL-1) INHIBITS PLATELET-NEUTROPHIL BINDING IN-VITRO
Authors: DORE M TIMONY G SCHAUB RG SYPEK JP
Citation: M. Dore et al., SOLUBLE P-SELECTIN GLYCOPROTEIN LIGAND-1 (SPSGL-1) INHIBITS PLATELET-NEUTROPHIL BINDING IN-VITRO, The FASEB journal, 12(5), 1998, pp. 6104-6104
SOLUBLE RECOMBINANT HUMAN P-SELECTION GLYCOPROTEIN LIGAND-1 (SPSGL-1), DECREASES INTESTINAL LESIONS IN HLA-B27 TRANSGENIC RATS AND IN ACETIC ACID-INDUCED COLITIS IN SPRAGUE-DAWLEY RATS
Authors: ALBERT LM PATEL U FERRANTI TJ AHMED A SCHAUB RG KEITH JC
Citation: Lm. Albert et al., SOLUBLE RECOMBINANT HUMAN P-SELECTION GLYCOPROTEIN LIGAND-1 (SPSGL-1), DECREASES INTESTINAL LESIONS IN HLA-B27 TRANSGENIC RATS AND IN ACETIC ACID-INDUCED COLITIS IN SPRAGUE-DAWLEY RATS, Gastroenterology, 114(4), 1998, pp. 3765-3765
CONJUNCTIVE TREATMENT WITH SOLUBLE P-SELECTIN GLYCOPROTEIN LIGAND-1 ACCELERATES THROMBOLYSIS AND PREVENTS REOCCLUSION IN A PORCINE MODEL
Authors: KUMAR A VILLANI MP PATEL UK KEITH JC SCHAUB RG
Citation: A. Kumar et al., CONJUNCTIVE TREATMENT WITH SOLUBLE P-SELECTIN GLYCOPROTEIN LIGAND-1 ACCELERATES THROMBOLYSIS AND PREVENTS REOCCLUSION IN A PORCINE MODEL, Circulation, 98(17), 1998, pp. 202-202
OPTIMAL SCHEDULING OF INTERLEUKIN-12 AND CHEMOTHERAPY IN THE MURINE MB-49 BLADDER-CARCINOMA AND B16 MELANOMA
Authors: TEICHER BA ARA G BUXTON D LEONARD J SCHAUB RG
Citation: Ba. Teicher et al., OPTIMAL SCHEDULING OF INTERLEUKIN-12 AND CHEMOTHERAPY IN THE MURINE MB-49 BLADDER-CARCINOMA AND B16 MELANOMA, Clinical cancer research, 3(9), 1997, pp. 1661-1667
REGULATION OF THE INFLAMMATORY RESPONSE IN ANIMAL-MODELS OF MULTIPLE-SCLEROSIS BY INTERLEUKIN-12
Authors: LEONARD JP WALDBURGER KE SCHAUB RG SMITH T HEWSON AK CUZNER ML GOLDMAN SJ
Citation: Jp. Leonard et al., REGULATION OF THE INFLAMMATORY RESPONSE IN ANIMAL-MODELS OF MULTIPLE-SCLEROSIS BY INTERLEUKIN-12, Critical reviews in immunology, 17(5-6), 1997, pp. 545-553
IMMUNOREACTIVE MACROPHAGE-COLONY-STIMULATING FACTOR IS INCREASED IN ATHEROSCLEROTIC LESIONS OF WATANABE HERITABLE HYPERLIPIDEMIC RABBITS AFTER RECOMBINANT HUMAN MACROPHAGE-COLONY-STIMULATING FACTOR THERAPY
Authors: DONNELLY LH BREE MP HUNTER SE KEITH JC SCHAUB RG
Citation: Lh. Donnelly et al., IMMUNOREACTIVE MACROPHAGE-COLONY-STIMULATING FACTOR IS INCREASED IN ATHEROSCLEROTIC LESIONS OF WATANABE HERITABLE HYPERLIPIDEMIC RABBITS AFTER RECOMBINANT HUMAN MACROPHAGE-COLONY-STIMULATING FACTOR THERAPY, Molecular reproduction and development, 46(1), 1997, pp. 92-95
RECOMBINANT MURINE IL-12 (RMIL-12) ALTERS IMMUNOREACTIVE INOS IN LESIONS OF LEISHMANIA MAJOR-INFECTED SUSCEPTIBLE BALB C MICE/
Authors: ERICKSON J DONNELLY LH LAVIGNE L CHUNG C KEITH JC SCHAUB RG SYPEK J SCHOPF L
Citation: J. Erickson et al., RECOMBINANT MURINE IL-12 (RMIL-12) ALTERS IMMUNOREACTIVE INOS IN LESIONS OF LEISHMANIA MAJOR-INFECTED SUSCEPTIBLE BALB C MICE/, The FASEB journal, 11(3), 1997, pp. 1935-1935
HIGH-MOLECULAR-WEIGHT FACTOR-IX AGGREGATE ISOLATED FROM A HIGHLY PURIFIED PLASMA-DERIVED CONCENTRATE DOES NOT CORRECT HEMOSTASIS IN THE HEMOPHILIA-B DOG
Authors: SIGMAN JL READ MS STEWART PF KEITH JC GARZONE P MCCARTHY K SCHAUB RG BRINKHOUS KM
Citation: Jl. Sigman et al., HIGH-MOLECULAR-WEIGHT FACTOR-IX AGGREGATE ISOLATED FROM A HIGHLY PURIFIED PLASMA-DERIVED CONCENTRATE DOES NOT CORRECT HEMOSTASIS IN THE HEMOPHILIA-B DOG, Thrombosis and haemostasis, 1997, pp. 896-896
THE PHARMACOKINETICS OF FULLY GAMMA-CARBOXYLATED FACTOR-IX AND FACTOR-IX LACKING GAMMA-CARBOXYLATION AT GKU-40 ARE SIMILAR IN THE HEMOPHILIA-B DOG
Authors: MCCARTHY KP BRINKHOUS KM STEWART PF SIGMAN JL READ MS TIMONY GA RUP BJ MORRIS D KEITH JC SCHAUB RG GARZONE PD
Citation: Kp. Mccarthy et al., THE PHARMACOKINETICS OF FULLY GAMMA-CARBOXYLATED FACTOR-IX AND FACTOR-IX LACKING GAMMA-CARBOXYLATION AT GKU-40 ARE SIMILAR IN THE HEMOPHILIA-B DOG, Thrombosis and haemostasis, 1997, pp. 900-900
FACTOR-IX LACKING GAMMA-CARBOXYLATION OF GLU40 IS EQUALLY EFFECTIVE AS FULLY GAMMA-CARBOXLATED FACTOR-IX AT CORRECTING HEMOSTASIS IN THE HEMOPHILIA-B DOG
Authors: STEWART PF SIGMAN JL READ MS KEITH JC GARZONE P MCCARTHY K SCHAUB RG BRINKHOUS KM
Citation: Pf. Stewart et al., FACTOR-IX LACKING GAMMA-CARBOXYLATION OF GLU40 IS EQUALLY EFFECTIVE AS FULLY GAMMA-CARBOXLATED FACTOR-IX AT CORRECTING HEMOSTASIS IN THE HEMOPHILIA-B DOG, Thrombosis and haemostasis, 1997, pp. 902-902
LUMINAL COLONIC TREATMENT WITH RECOMBINANT HUMAN INTERLEUKIN-11 (RHIL-11) DECREASES BOWEL LESIONS IN HLA-B27 TRANSGENIC RATS
Authors: ALBERT LM SOLEY E INGRAM R WARNE N FERRANTI TJ ERICKSON JE MASON LE DONNELLY LH SCHAUB RG KEITH JC
Citation: Lm. Albert et al., LUMINAL COLONIC TREATMENT WITH RECOMBINANT HUMAN INTERLEUKIN-11 (RHIL-11) DECREASES BOWEL LESIONS IN HLA-B27 TRANSGENIC RATS, Gastroenterology, 112(4), 1997, pp. 920-920
IMMUNOREGULATION BY INTERLEUKIN-12 IN MB49.1 TUMOR-BEARING MICE - CELLULAR AND CYTOKINE-MEDIATED EFFECTOR MECHANISMS
Authors: HUNTER SE WALDBURGER KE THIBODEAUX DK SCHAUB RG GOLDMAN SJ LEONARD JP
Citation: Se. Hunter et al., IMMUNOREGULATION BY INTERLEUKIN-12 IN MB49.1 TUMOR-BEARING MICE - CELLULAR AND CYTOKINE-MEDIATED EFFECTOR MECHANISMS, European Journal of Immunology, 27(12), 1997, pp. 3438-3446
SUBCUTANEOUS NEONATAL ADMINISTRATION OF RECOMBINANT FACTOR-IX (BENEFIX(TM)) INDUCES IMMUNE TOLERANCE IN HEMOPHILIA-B DOGS
Authors: RUSSELL KE STEWART PF ELWELL DR NICHOLS TC BELLINGER DA BRINKHOUS KM RUP BJ KEITH JC LEITERMANN K MCCARTHY KP SCHAUB RG READ MS
Citation: Ke. Russell et al., SUBCUTANEOUS NEONATAL ADMINISTRATION OF RECOMBINANT FACTOR-IX (BENEFIX(TM)) INDUCES IMMUNE TOLERANCE IN HEMOPHILIA-B DOGS, Blood, 90(10), 1997, pp. 2662-2662
RECOMBINANT HUMAN INTERLEUKIN-11 DECREASES ADJUVANT-INDUCED ARTHRITISIN LEWIS RATS
Authors: ALBERT L ERICKSON JE MASON LE FERRANTI TJ PATEL UK DONNELLY LH KEITH JC SCHAUB RG
Citation: L. Albert et al., RECOMBINANT HUMAN INTERLEUKIN-11 DECREASES ADJUVANT-INDUCED ARTHRITISIN LEWIS RATS, Arthritis and rheumatism, 40(9), 1997, pp. 145-145
RECOMBINANT HUMAN SOLUBLE P-SELECTIN GLYCOPROTEIN LIGAND-1 DECREASES ADJUVANT-INDUCED ARTHRITIS IN LEWIS RATS
Authors: ALBERT L ERICKSON JE MASON LE FERRANTI TJ PATEL UK DONNELLY LH KEITH JC SCHAUB RG
Citation: L. Albert et al., RECOMBINANT HUMAN SOLUBLE P-SELECTIN GLYCOPROTEIN LIGAND-1 DECREASES ADJUVANT-INDUCED ARTHRITIS IN LEWIS RATS, Arthritis and rheumatism, 40(9), 1997, pp. 261-261
THROMBOPOIETIC ACTIVITY OF RECOMBINANT HUMAN INTERLEUKIN-11 (RHUIL-11) IN NORMAL AND MYELOSUPPRESSED NONHUMAN-PRIMATES
Authors: SCHLERMAN FJ BREE AG KAVIANI M NAGLE SL DONNELLY LH MASON LE SCHAUB RG GRUPP SA GOLDMAN SJ
Citation: Fj. Schlerman et al., THROMBOPOIETIC ACTIVITY OF RECOMBINANT HUMAN INTERLEUKIN-11 (RHUIL-11) IN NORMAL AND MYELOSUPPRESSED NONHUMAN-PRIMATES, Stem cells, 14(5), 1996, pp. 517-532
RECOMBINANT HUMAN INTERLEUKIN-11 PREVENTS HYPOTENSION IN LPS-TREATED ANESTHETIZED RABBITS
Authors: MISRA BR FERRANTI TJ DONNELLY LH ERICKSON JE SCHAUB RG KEITH JC
Citation: Br. Misra et al., RECOMBINANT HUMAN INTERLEUKIN-11 PREVENTS HYPOTENSION IN LPS-TREATED ANESTHETIZED RABBITS, Journal of endotoxin research, 3(4), 1996, pp. 297-305
IN-VIVO STUDIES WITH INTERLEUKIN-12 ALONE AND IN COMBINATION WITH MONOCYTE COLONY-STIMULATING FACTOR AND OR FRACTIONATED RADIATION TREATMENT/
Authors: TEICHER BA ARA G MENON K SCHAUB RG
Citation: Ba. Teicher et al., IN-VIVO STUDIES WITH INTERLEUKIN-12 ALONE AND IN COMBINATION WITH MONOCYTE COLONY-STIMULATING FACTOR AND OR FRACTIONATED RADIATION TREATMENT/, International journal of cancer, 65(1), 1996, pp. 80-84
RECOMBINANT HUMAN FACTOR-IX - REPLACEMENT THERAPY, PROPHYLAXIS, AND PHARMACOKINETICS IN CANINE HEMOPHILIA-B
Authors: BRINKHOUS KM SIGMAN JL READ MS STEWART PF MCCARTHY KP TIMONY GA LEPPANEN SD RUP BJ KEITH JC GARZONE PD SCHAUB RG
Citation: Km. Brinkhous et al., RECOMBINANT HUMAN FACTOR-IX - REPLACEMENT THERAPY, PROPHYLAXIS, AND PHARMACOKINETICS IN CANINE HEMOPHILIA-B, Blood, 88(7), 1996, pp. 2603-2610
RECOMBINANT HUMAN MACROPHAGE-COLONY-STIMULATING FACTOR IN NONHUMAN-PRIMATES - SELECTIVE EXPANSION OF A CD16(-KILLER-CELLS() MONOCYTE SUBSETWITH PHENOTYPIC SIMILARITY TO PRIMATE NATURAL)
Authors: MUNN DH BREE AG BEALL AC KAVIANI MD SABIO H SCHAUB RG ALPAUGH RK WEINER LM GOLDMAN SJ
Citation: Dh. Munn et al., RECOMBINANT HUMAN MACROPHAGE-COLONY-STIMULATING FACTOR IN NONHUMAN-PRIMATES - SELECTIVE EXPANSION OF A CD16(-KILLER-CELLS() MONOCYTE SUBSETWITH PHENOTYPIC SIMILARITY TO PRIMATE NATURAL), Blood, 88(4), 1996, pp. 1215-1224
SUBCUTANEOUS BIOAVAILABILITY OF RECOMBINANT FACTOR-IX (BENEFIX(TM)) IN HEALTHY BEAGLE DOGS AND CYNOMOLGUS MONKEYS
Authors: MCCARTHY KP TIMONY GA FERRANTI TJ MISRA BR KEITH JC BREE AG SCHLERMAN FJ RESMINI C HAIRE TC SCHAUB RG GARZONE PD
Citation: Kp. Mccarthy et al., SUBCUTANEOUS BIOAVAILABILITY OF RECOMBINANT FACTOR-IX (BENEFIX(TM)) IN HEALTHY BEAGLE DOGS AND CYNOMOLGUS MONKEYS, Blood, 88(10), 1996, pp. 3000-3000
EFFECTS OF RECOMBINANT HUMAN INTERLEUKIN-II ON THE ACTIVATION AND MORPHOLOGY OF PERIPHERAL-BLOOD PLATELETS AND MEGAKARYOCYTES IN NONHUMAN-PRIMATES
Authors: KAVIANI MD MASON LE BREE AG NAGLE SL SCHLERMAN FJ DONNELLY LH SCHAUB RG ZUCKERFRANKLIN D GOLDMAN SJ
Citation: Md. Kaviani et al., EFFECTS OF RECOMBINANT HUMAN INTERLEUKIN-II ON THE ACTIVATION AND MORPHOLOGY OF PERIPHERAL-BLOOD PLATELETS AND MEGAKARYOCYTES IN NONHUMAN-PRIMATES, Blood, 88(10), 1996, pp. 94-94
SUBCUTANEOUS RECOMBINANT FACTOR-IX (BENEFIX(TM)) ADMINISTRATION PRODUCES THERAPEUTIC LEVELS OF FIX ACTIVITY IN HEMOPHILIA-B DOGS
Authors: BRINKHOUS KM SIGMAN JL READ MS STEWART PF BUSH L BARTLETT E RUP B KEITH JC GARZONE P MCCARTHY K SCHAUB RG
Citation: Km. Brinkhous et al., SUBCUTANEOUS RECOMBINANT FACTOR-IX (BENEFIX(TM)) ADMINISTRATION PRODUCES THERAPEUTIC LEVELS OF FIX ACTIVITY IN HEMOPHILIA-B DOGS, Blood, 88(10), 1996, pp. 1757-1757
RECOMBINANT HUMAN INTERLEUKIN-11 DECREASES ARTHRITIS IN HLA-B27 TRANSGENIC RATS
Authors: KEITH JC ALBERT L ERICKSON JE MASON LE FERRANTI TJ MISRA BR DONNELLY LH SCHAUB RG
Citation: Jc. Keith et al., RECOMBINANT HUMAN INTERLEUKIN-11 DECREASES ARTHRITIS IN HLA-B27 TRANSGENIC RATS, Arthritis and rheumatism, 39(9), 1996, pp. 1613-1613
ADOPTIVE TRANSFER OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS AFTER IN-VITRO TREATMENT WITH RECOMBINANT MURINE INTERLEUKIN-12 - PREFERENTIALEXPANSION OF INTERFERON-GAMMA-PRODUCING CELLS AND INCREASED EXPRESSION OF MACROPHAGE-ASSOCIATED INDUCIBLE NITRIC-OXIDE SYNTHASE AS IMMUNOMODULATORY MECHANISMS
Authors: WALDBURGER KE HASTINGS RC SCHAUB RG GOLDMAN SJ LEONARD JP
Citation: Ke. Waldburger et al., ADOPTIVE TRANSFER OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS AFTER IN-VITRO TREATMENT WITH RECOMBINANT MURINE INTERLEUKIN-12 - PREFERENTIALEXPANSION OF INTERFERON-GAMMA-PRODUCING CELLS AND INCREASED EXPRESSION OF MACROPHAGE-ASSOCIATED INDUCIBLE NITRIC-OXIDE SYNTHASE AS IMMUNOMODULATORY MECHANISMS, The American journal of pathology, 148(2), 1996, pp. 375-382
Risultati: 1-25 | 26-41